Broker Arden has initiated research on Aquis-quoted Goodbody Health (LON: GDBY) and set a 10p a share target price. The cannabis products and health testing supplier is expected to grow rapidly over the next two years.
Goodbody Health was previously known as Sativa Wellness Group, and it was set up in 2018. The initial CBD products supply business has been broadened into Covid testing clinics, that have in turn broadened the range of tests they offer. The strategy is to focus on independent pharmacies for testing business.
Currently 94% of testing revenues relate to Covid, but other blo...
